Indian Drugmaker Stelis Biopharma to Produce 200 Million Doses of Russia's Sputnik V - Newshunt | Latest and Breaking News, India News & World News

Indian Drugmaker Stelis Biopharma to Produce 200 Million Doses of Russia's Sputnik V

The developer of Russia's Sputnik V coronavirus vaccine said Friday it had signed a partnership with an India-based drugmaker for the production of 200 million doses of the two-dose jab.


from India News Today: India Live News | Latest India News Online | Current News Headline - News18
Read The Rest:indianexpress...

No comments:

Powered by Blogger.